A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Carol Aghajanian, Virginia L. Filiaci, Don S. Dizon, Jay W. Carlson, Matthew A. Powell, Angeles Alvarez Secord, Krishnansu S. Tewari, David Bender, David M. O’Malley, Ashley Stuckey,

Gynecologic Oncology · 2018 · 143 citations · 25 references

DOIFull text

Open access

Concepts

References

25